|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/10/24 Accustem Sciences Inc. 8-K:4,9 4/04/24 11:203K M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 39K 2: EX-16.1 Letter re: a Change in Accountant HTML 6K 6: R1 Cover HTML 45K 8: XML IDEA XML File -- Filing Summary XML 11K 11: XML XBRL Instance -- form8-k_htm XML 16K 7: EXCEL IDEA Workbook of Financial Report Info XLSX 8K 4: EX-101.LAB XBRL Labels -- acut-20240404_lab XML 96K 5: EX-101.PRE XBRL Presentations -- acut-20240404_pre XML 64K 3: EX-101.SCH XBRL Schema -- acut-20240404 XSD 12K 9: JSON XBRL Instance as JSON Data -- MetaLinks 25± 34K 10: ZIP XBRL Zipped Folder -- 0001493152-24-014171-xbrl Zip 16K
Exhibit 16.1
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Ladies and Gentlemen:
We have read the statements made by Accustem Sciences Inc. (the “registrant”) under Item 4.01 of its Form 8-K dated April 10, 2024 and are in agreement with the statements therein concerning Mazars USA LLP. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Mazars USA LLP
New York, NY
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/10/24 | None on these Dates | ||
| For Period end: | 4/4/24 | |||
| List all Filings | ||||